{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-14",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "79481-6308",
      "generic_name": "Aacetaminophen, Dextromethorphan HBr and Guaifenesi",
      "labeler_name": "MEIJER DISTRIBUTION INC",
      "brand_name": "Meijer Adult MS Severe Multi-Symptom Cough Cold Flu",
      "brand_name_suffix": "Cough Cold Flu",
      "active_ingredients": [
        {
          "name": "ACETAMINOPHEN",
          "strength": "650 mg/20mL"
        },
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "20 mg/20mL"
        },
        {
          "name": "GUAIFENESIN",
          "strength": "400 mg/20mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "79481-6308-8",
          "description": "1 BOTTLE in 1 CARTON (79481-6308-8)  / 237 mL in 1 BOTTLE",
          "marketing_start_date": "20260828",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "LIQUID",
      "spl_id": "9bff0183-ddcc-49a3-b7b8-e82b489c0d10",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260828",
      "product_id": "79481-6308_9bff0183-ddcc-49a3-b7b8-e82b489c0d10",
      "application_number": "M012",
      "brand_name_base": "Meijer Adult MS Severe Multi-Symptom",
      "pharm_class": [
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]"
      ]
    }
  ]
}